News

Knight Therapeutics Inc. (TSX: GUD) (“Knight”), a pan-American (ex-USA) specialty pharmaceutical company, will release its second quarter 2025 financial results on Thursday, August 7, 2025 prior to ...
LOS ANGELES, July 31, 2025 (GLOBE NEWSWIRE) -- Daily Journal Corporation is issuing this press release to provide additional ...